Globus Medical, Inc., a prominent player in the healthcare equipment and supplies industry, continues to focus its operations on the specialized field of spinal care. Operating exclusively within the design, development, and commercialization of medical devices, the company has established itself as a dedicated provider of solutions aimed at facilitating healing for patients suffering from various spine disorders. Their product portfolio is characterized by a commitment to innovation, featuring both advanced fusion technologies and disruptive, technology-based medical products.
The company’s financial standing reflects its significant presence in the healthcare sector. As a publicly traded entity on the New York Stock Exchange, Globus Medical maintains a substantial market capitalization of approximately $9.34 billion USD. Since its initial public offering on August 3, 2012, the company has navigated various market cycles, maintaining a price-to-earnings ratio of 17.34.
Recent market data highlights a period of consolidation for the company’s stock. As of the close of trading on November 16, 2026, the share price stood at $69.99. This figure sits near the lower end of its 52-week trading range, which has seen a high of $101.40 recorded on January 7, 2026, and a low of $69.49 on November 16, 2026. Despite these recent fluctuations, Globus Medical remains a key contributor to the medical device landscape through its specialized focus on spinal health innovation.




